Chapter Six Implications of Protein- and Peptide-Based Nanoparticles as Potential Vehicles for Anticancer Drugs

Publication date: 2015 Source:Advances in Protein Chemistry and Structural Biology, Volume 98 Author(s): Ahmed O. Elzoghby , Mayada M. Elgohary , Nayra M. Kamel Protein-based nanocarriers have gained considerable attention as colloidal carrier systems for the delivery of anticancer drugs. Protein nanocarriers possess various advantages including their low cytotoxicity, abundant renewable sources, high drug-binding capacity, and significant uptake into the targeted tumor cells. Moreover, the unique protein structure offers the possibility of site-specific drug conjugation and tumor targeting using various ligands modifying the surface of protein nanocarriers. In this chapter, we highlight the most important applications of protein nanoparticles (NPs) for the delivery of anticancer drugs. We examine the various techniques that have been utilized for the preparation of anticancer drug-loaded protein NPs. Finally, the current chapter also reviews the major outcomes of the in vitro and in vivo investigations of surface-modified tumor-targeted protein NPs.
Source: Advances in Protein Chemistry and Structural Biology - Category: Biochemistry Source Type: research